Pegylated rhG-CSF (HHPG-19K)

pegylated recombinant human granulocyte colony-stimulating factor · Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegylated rhG-CSF (HHPG-19K), covering 2014-04-22 to 2014-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy [Phase 2]

See pricing